REMIFENTANIL VIATRIS 2 mg clinical trials

SYMBOL CLINICAL : Treatment of severe ocular chemical burns by subconjunctival injection of allogeneic mesenchymal stem cells: a multicentre, single-arm, open-label phase II trial

This study is looking at a new way to treat severe eye burns caused by chemicals. It uses special cells from donors, called mesenchymal stem cells, injected near the eye. Doctors want to see if this treatment can stop the eye from developing a hole in its surface.